MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) Receivables

The latest receivables for MTACU is $5.2M as of March 2026. That compares with $5.5M in the prior-year period — down 4.4% year over year. Investors often review this figure alongside MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, MTACU's receivables moved from $5.5M to $5.2M — a 4.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)'s operating scale or balance-sheet position.

A receivables figure of $5.2M for MTACU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MTACU's receivables ($5.2M), review year-over-year change from $5.5M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.